Bank of America’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
31,569
-2,111
| -6% | -$71.2K | ﹤0.01% | 4420 |
|
|
2025
Q1 | $1.07M | Buy |
33,680
+5,578
| +20% | +$177K | ﹤0.01% | 4313 |
|
|
2024
Q4 | $1.09M | Sell |
28,102
-8,638
| -24% | -$336K | ﹤0.01% | 4181 |
|
|
2024
Q3 | $1.65M | Buy |
36,740
+24,347
| +196% | +$1.1M | ﹤0.01% | 3975 |
|
|
2024
Q2 | $518K | Buy |
12,393
+2,374
| +24% | +$99.1K | ﹤0.01% | 4563 |
|
|
2024
Q1 | $456K | Buy |
10,019
+6,113
| +157% | +$278K | ﹤0.01% | 4602 |
|
|
2023
Q4 | $181K | Buy |
3,906
+270
| +7% | +$12.5K | ﹤0.01% | 5210 |
|
|
2023
Q3 | $148K | Buy |
3,636
+82
| +2% | +$3.34K | ﹤0.01% | 5203 |
|
|
2023
Q2 | $172K | Sell |
3,554
-3,759
| -51% | -$182K | ﹤0.01% | 5105 |
|
|
2023
Q1 | $360K | Buy |
7,313
+541
| +8% | +$26.7K | ﹤0.01% | 4823 |
|
|
2022
Q4 | $343K | Sell |
6,772
-47
| -0.7% | -$2.38K | ﹤0.01% | 4920 |
|
|
2022
Q3 | $342K | Buy |
6,819
+1,493
| +28% | +$74.9K | ﹤0.01% | 4890 |
|
|
2022
Q2 | $261K | Sell |
5,326
-342
| -6% | -$16.8K | ﹤0.01% | 5166 |
|
|
2022
Q1 | $341K | Sell |
5,668
-973
| -15% | -$58.5K | ﹤0.01% | 5359 |
|
|
2021
Q4 | $527K | Sell |
6,641
-10,292
| -61% | -$817K | ﹤0.01% | 5055 |
|
|
2021
Q3 | $1.5M | Buy |
16,933
+11,647
| +220% | +$1.03M | ﹤0.01% | 4023 |
|
|
2021
Q2 | $527K | Sell |
5,286
-5,915
| -53% | -$590K | ﹤0.01% | 4673 |
|
|
2021
Q1 | $1.01M | Buy |
11,201
+10,976
| +4,878% | +$987K | ﹤0.01% | 4243 |
|
|
2020
Q4 | $22K | Buy |
+225
| New | +$22K | ﹤0.01% | 5796 |
|